Wan-lin Li, Huan-huan AN, yan Meng, Jin-yu CHI. Research progress of PDZK1 in anti-atherosclerosis[J]. Chinese Heart Journal, 2023, 35(5): 597-599, 603. DOI: 10.12125/j.chj.202203017
    Citation: Wan-lin Li, Huan-huan AN, yan Meng, Jin-yu CHI. Research progress of PDZK1 in anti-atherosclerosis[J]. Chinese Heart Journal, 2023, 35(5): 597-599, 603. DOI: 10.12125/j.chj.202203017

    Research progress of PDZK1 in anti-atherosclerosis

    • PDZK1: a member of the protein family of Na+/H+ exchange regulators,is considered to be a classic cell membrane scaffold/adapter protein. Nowadays it is clear that PDZK1 can regulate the pathophysiological process of atherosclerosis by participating in lipid metabolism and HDL mediated signal transduction pathway in macrophages, endothelial cells and vascular smooth muscle cells. In the future, we should study the specific regulatory mechanism of PDZK1 in atherosclerosis deeply, so as to provide new and more effective potential targets for disease prevention and prognosis.
    • loading

    Catalog

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return